Nobel Prize Winner's Premonition About Nuclear Energy Comes True

Nobel Prize-winning physicist Dr. Burton Richter made a controversial statement 15 years ago. Despite skepticism, he predicted that more nuclear power was needed to help combat the damaging effects of a changing climate.

As it turns out, he was correct... Experts now advise that nuclear power is the ONLY realistic way for the world to meet climate goals and achieve energy independence.

Will This Nuclear Revival Send Uranium A Bull Run?

FOLD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $3,435,679.48

Amicus Therapeutics Insider Trading History Chart

Amicus Therapeutics Share Price & Price History

^$11.69

▼ -0.28 (-2.34%)

As of 12/9/2022 06:21 PM ET

Days: 30 | 90 | 365

"We need batteries. Literally everywhere."

From Investing Trends | Ad

Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."

Read about this company's once-in-a-lifetime offer

Amicus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/1/2022	Bradley L Campbell	CEO	Sell	5,485	$12.20	$66,917.00	689,618
12/1/2022	John F Crowley	Chairman	Sell	11,347	$12.20	$138,433.40	801,922
11/15/2022	John F Crowley	Chairman	Sell	10,468	$11.64	$121,847.52	813,269
11/1/2022	Bradley L Campbell	CEO	Sell	5,470	$10.01	$54,754.70	689,618
11/1/2022	John F Crowley	Chairman	Sell	11,346	$10.32	$117,090.72	823,737
10/17/2022	John F Crowley	Chairman	Sell	10,468	$10.90	$114,101.20	835,083
10/3/2022	Bradley L Campbell	CEO	Sell	5,470	$10.53	$57,599.10	689,618
10/3/2022	John F Crowley	Chairman	Sell	11,346	$10.75	$121,969.50	845,551
9/15/2022	John F Crowley	Chairman	Sell	10,468	$10.66	$111,588.88	856,897
8/1/2022	Bradley L Campbell	CEO	Sell	5,470	$10.03	$54,864.10	689,618
8/1/2022	Ellen Rosenberg	Insider	Sell	11,123	$10.02	$111,452.46	280,707
8/1/2022	John F Crowley	Chairman	Sell	11,346	$9.96	$113,006.16	889,179
7/15/2022	John F Crowley	CEO	Sell	10,468	$10.86	$113,682.48	900,525
7/1/2022	Bradley L Campbell	COO	Sell	5,470	$10.72	$58,638.40	689,618
7/1/2022	John F Crowley	CEO	Sell	11,346	$10.78	$122,309.88	910,993
6/21/2022	Bradley L Campbell	COO	Sell	16,410	$10.00	$164,100.00	689,618
6/21/2022	Ellen Rosenberg	Insider	Sell	11,122	$10.00	$111,220.00	291,830
6/17/2022	Daphne Quimi	CFO	Sell	4,396	$9.00	$39,564.00	345,507
6/15/2022	John F Crowley	CEO	Sell	10,468	$8.01	$83,848.68	922,339
6/3/2022	John F Crowley	CEO	Sell	11,346	$8.00	$90,768.00	932,807
5/23/2022	John F Crowley	CEO	Sell	21,814	$8.00	$174,512.00	944,153
5/2/2022	Margaret G. Mcglynn	Director	Sell	15,000	$6.99	$104,850.00	38,034
4/18/2022	John F Crowley	CEO	Sell	2,214	$8.04	$17,800.56	974,221
4/7/2022	Ellen Rosenberg	Insider	Sell	11,018	$9.06	$99,823.08	302,952
3/18/2022	Bradley L Campbell	COO	Sell	10,940	$10.00	$109,400.00
1/18/2022	John F Crowley	CEO	Sell	8,564	$10.23	$87,609.72
1/5/2022	John F Crowley	CEO	Sell	63,543	$12.18	$773,953.74
1/3/2022	Bradley L Campbell	COO	Sell	5,470	$11.86	$64,874.20
12/22/2021	Bradley L Campbell	COO	Sell	3,000	$11.70	$35,100.00
12/1/2021	Bradley L Campbell	COO	Sell	10,515	$11.00	$115,665.00
11/15/2021	John F Crowley	CEO	Sell	24,935	$11.75	$292,986.25
11/3/2021	John F Crowley	CEO	Sell	27,739	$12.00	$332,868.00
11/1/2021	Bradley L Campbell	COO	Sell	10,515	$11.32	$119,029.80
11/1/2021	Burke W. Whitman	Director	Buy	1,500	$10.49	$15,735.00
11/1/2021	John F Crowley	CEO	Sell	7,819	$10.80	$84,445.20
10/15/2021	John F Crowley	CEO	Sell	22,000	$11.22	$246,840.00
10/1/2021	Bradley L Campbell	COO	Sell	10,515	$10.00	$105,150.00
10/1/2021	Burke W. Whitman	Director	Buy	1,500	$9.56	$14,340.00
10/1/2021	John F Crowley	CEO	Sell	7,500	$10.00	$75,000.00
9/15/2021	John F Crowley	CEO	Sell	22,000	$11.08	$243,760.00	861,845
9/3/2021	John F Crowley	CEO	Sell	5,238	$12.02	$62,960.76
9/3/2021	Samantha Prout	Insider	Sell	4,925	$12.01	$59,149.25	85,150
9/1/2021	Bradley L Campbell	COO	Sell	10,515	$11.50	$120,922.50
9/1/2021	Burke W. Whitman	Director	Buy	1,500	$11.41	$17,115.00
9/1/2021	John F Crowley	CEO	Sell	7,500	$11.50	$86,250.00	839,845
8/23/2021	Samantha Prout	Insider	Sell	5,045	$11.00	$55,495.00	83,170
8/16/2021	John F Crowley	CEO	Sell	22,000	$10.27	$225,940.00	869,345
8/5/2021	Bradley L Campbell	COO	Sell	21,028	$10.02	$210,700.56
8/5/2021	John F. Crowley	CEO	Sell	37,000	$10.03	$371,110.00	884,345
8/2/2021	Burke W. Whitman	Director	Buy	1,500	$9.28	$13,920.00	60,582
7/12/2021	John F Crowley	CEO	Sell	14,885	$9.31	$138,579.35	862,345
7/1/2021	Burke W. Whitman	Director	Buy	1,500	$9.60	$14,400.00	59,082
6/15/2021	John F Crowley	CEO	Sell	22,000	$10.26	$225,720.00	899,230
6/7/2021	Bradley L Campbell	COO	Sell	10,514	$10.01	$105,245.14	436,397
6/7/2021	John F Crowley	CEO	Sell	29,500	$10.01	$295,295.00	905,287
6/1/2021	Burke W. Whitman	Director	Buy	1,500	$9.24	$13,860.00	47,467
5/25/2021	Lynn Dorsey Bleil	Director	Buy	28,605	$8.74	$250,007.70	50,310
5/3/2021	Bradley L. Campbell	COO	Sell	10,514	$10.27	$107,978.78	422,536
5/3/2021	John F Crowley	CEO	Sell	7,500	$10.28	$77,100.00	884,730
5/3/2021	Margaret G. Mcglynn	Director	Sell	10,000	$10.27	$102,700.00	37,919
4/22/2021	John F Crowley	CEO	Sell	7,683	$10.01	$76,906.83	892,230
4/15/2021	John F Crowley	CEO	Sell	22,000	$10.09	$221,980.00	921,913
4/1/2021	Bradley L Campbell	COO	Sell	10,514	$10.03	$105,455.42	389,371
4/1/2021	Burke W. Whitman	Director	Buy	1,500	$10.00	$15,000.00	44,467
4/1/2021	John F Crowley	CEO	Sell	7,500	$10.00	$75,000.00	821,524
3/22/2021	John F Crowley	CEO	Sell	7,682	$10.29	$79,047.78	829,024
3/15/2021	John F Crowley	CEO	Sell	22,000	$10.77	$236,940.00	858,706
1/20/2021	John F Crowley	CEO	Sell	50,000	$21.51	$1,075,500.00	940,996
1/15/2021	John F Crowley	CEO	Sell	22,000	$22.24	$489,280.00	940,996
1/4/2021	Bradley L Campbell	COO	Sell	10,514	$22.17	$233,095.38	347,215
1/4/2021	Burke W. Whitman	Director	Buy	1,500	$23.17	$34,755.00	39,967
1/4/2021	John F Crowley	CEO	Sell	7,500	$22.17	$166,275.00	807,226
12/21/2020	Daphne Quimi	CFO	Sell	5,000	$24.09	$120,450.00	249,344
12/15/2020	John F Crowley	CEO	Sell	22,000	$23.91	$526,020.00	845,513
12/14/2020	Hung Do	Insider	Sell	111,125	$23.88	$2,653,665.00	409,682
12/1/2020	Bradley L Campbell	COO	Sell	24,783	$22.77	$564,308.91	363,547
12/1/2020	Burke W. Whitman	Director	Buy	1,500	$23.50	$35,250.00	38,467
12/1/2020	John F Crowley	CEO	Sell	7,500	$22.77	$170,775.00	823,513
11/4/2020	Samantha Prout	Insider	Sell	5,931	$20.00	$118,620.00	22,472
11/2/2020	Bradley L Campbell	COO	Sell	24,782	$17.87	$442,854.34	363,546
11/2/2020	Burke W. Whitman	Director	Buy	1,500	$18.01	$27,015.00	36,967
11/2/2020	John F Crowley	CEO	Sell	33,875	$17.87	$605,346.25	864,888
10/9/2020	Hung Do	Insider	Sell	193,700	$15.03	$2,911,311.00	564,507
10/1/2020	Burke W. Whitman	Director	Buy	1,500	$14.28	$21,420.00	35,467
10/1/2020	Daphne Quimi	CFO	Sell	5,000	$14.02	$70,100.00	212,179
10/1/2020	John F Crowley	CEO	Sell	29,900	$14.02	$419,198.00	870,813
9/28/2020	Bradley L Campbell	COO	Sell	24,782	$13.89	$344,221.98	363,546
9/1/2020	Burke W. Whitman	Director	Buy	1,500	$14.62	$21,930.00	33,967
9/1/2020	John F Crowley	CEO	Sell	29,900	$14.18	$423,982.00	880,713
8/31/2020	Jay Barth	Insider	Sell	28,750	$14.74	$423,775.00	191,954
8/17/2020	John F Crowley	CEO	Sell	20,000	$14.89	$297,800.00	880,713
8/5/2020	Samantha Prout	Insider	Sell	198	$15.05	$2,979.90	17,333
7/27/2020	Jay Barth	Insider	Sell	30,000	$15.05	$451,500.00	193,204
7/16/2020	Ellen Rosenberg	Insider	Sell	30,000	$15.26	$457,800.00	225,169
7/15/2020	John F Crowley	CEO	Sell	20,000	$15.54	$310,800.00	900,368
7/9/2020	Jay Barth	Insider	Sell	44,447	$15.92	$707,596.24	174,763
7/8/2020	Bradley L Campbell	COO	Sell	2,500	$16.01	$40,025.00	341,264
7/7/2020	Jay Barth	Insider	Sell	178,988	$15.90	$2,845,909.20	214,735
7/2/2020	Samantha Prout	Insider	Sell	198	$15.80	$3,128.40	1,733
7/1/2020	Bradley L Campbell	COO	Sell	12,500	$15.47	$193,375.00	351,264
7/1/2020	Burke W. Whitman	Director	Buy	1,500	$15.20	$22,800.00	30,967
7/1/2020	Daphne Quimi	CFO	Sell	6,872	$15.47	$106,309.84	207,179
7/1/2020	John F Crowley	CEO	Sell	39,655	$15.48	$613,859.40	920,023
6/29/2020	Jay Barth	Insider	Sell	30,000	$15.51	$465,300.00	193,204
6/19/2020	Samantha Prout	Insider	Sell	3,366	$15.00	$50,490.00	20,501
6/17/2020	Jay Barth	Insider	Sell	1,904	$13.47	$25,646.88	165,108
6/15/2020	John F Crowley	CEO	Sell	20,000	$10.88	$217,600.00	920,186
6/1/2020	Bradley L Campbell	COO	Sell	17,502	$12.66	$221,575.32	365,355
6/1/2020	John F Crowley	CEO	Sell	9,755	$12.66	$123,498.30	909,941
6/1/2020	Michael Raab	Director	Sell	5,000	$12.65	$63,250.00	20,145
5/26/2020	Bradley L Campbell	COO	Sell	2,500	$13.01	$32,525.00	357,855
5/15/2020	John F Crowley	CEO	Sell	20,000	$11.44	$228,800.00	959,941
5/1/2020	Bradley L Campbell	COO	Sell	17,503	$11.33	$198,308.99	372,858
5/1/2020	John F Crowley	CEO	Sell	9,755	$11.32	$110,426.60	939,941
4/17/2020	Margaret G. Mcglynn	Director	Sell	10,000	$11.00	$110,000.00	32,064
4/15/2020	John F Crowley	CEO	Sell	20,000	$9.92	$198,400.00	969,696
4/7/2020	Bradley L Campbell	COO	Sell	2,500	$10.12	$25,300.00	365,358
4/1/2020	Bradley L Campbell	COO	Sell	15,003	$9.09	$136,377.27	363,014
4/1/2020	John F Crowley	CEO	Sell	9,755	$9.08	$88,575.40	909,081
3/20/2020	John F Crowley	CEO	Sell	20,000	$9.00	$180,000.00	938,836
3/5/2020	Bradley L Campbell	COO	Sell	2,500	$10.01	$25,025.00	358,014
3/2/2020	John F Crowley	CEO	Sell	9,755	$9.10	$88,770.50	918,836
2/5/2020	Bradley L Campbell	COO	Sell	2,500	$10.01	$25,025.00	365,517
2/3/2020	Bradley L Campbell	COO	Sell	15,003	$8.91	$133,676.73	378,020
2/3/2020	John F Crowley	CEO	Sell	9,754	$8.91	$86,908.14	938,345
1/15/2020	Bradley L Campbell	COO	Sell	5,064	$10.35	$52,412.40	370,520
1/15/2020	Ellen Rosenberg	Insider	Sell	22,100	$10.35	$228,735.00	185,350
1/15/2020	John F Crowley	CEO	Sell	100,000	$10.35	$1,035,000.00	1,058,339
1/9/2020	Bradley L Campbell	COO	Sell	2,500	$10.01	$25,025.00	347,695
1/9/2020	Daphne Quimi	CFO	Sell	15,000	$9.93	$148,950.00	166,969
1/9/2020	Margaret G. Mcglynn	Director	Sell	20,000	$10.00	$200,000.00	42,064
1/6/2020	Jay Barth	Insider	Sell	6,836	$9.28	$63,438.08	166,411
1/2/2020	Bradley L Campbell	COO	Sell	22,127	$9.58	$211,976.66	253,987
1/2/2020	Jay Barth	Insider	Sell	9,753	$9.55	$93,141.15	137,674
12/16/2019	John F Crowley	CEO	Sell	20,000	$9.55	$191,000.00	755,694

The Critical Minerals Race: U.S. v China

From Investing Trends | Ad

The U.S. is dangerously lacking in critical minerals such as cobalt, lithium, and rare earths needed to maintain our national security. China is aggressively locking up mines and production. But the U.S. is about to strike back with a forceful plan of action to increase domestic production.

See how investors could can take advantage

SEC Filings (Institutional Ownership Changes) for Amicus Therapeutics (NASDAQ:FOLD)

Institutional Buying and Selling by Quarter

Amicus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/8/2022	Bank of New York Mellon Corp	1,229,564	$12.84M	0.0%	+4.8%	0.438%
11/21/2022	California State Teachers Retirement System	289,708	$3.03M	0.0%	-2.6%	0.103%
11/18/2022	Ambassador Advisors LLC	316,219	$3.30M	0.8%	N/A	0.113%
11/18/2022	SevenOneSeven Capital Management	29,560	$0.31M	0.7%	N/A	0.011%
11/16/2022	Balyasny Asset Management LLC	1,684,968	$17.59M	0.1%	-21.7%	0.600%
11/16/2022	BNP Paribas Arbitrage SNC	351,746	$3.67M	0.0%	+2.4%	0.125%
11/15/2022	Neuberger Berman Group LLC	472,394	$4.93M	0.0%	-0.8%	0.168%
11/15/2022	Alliancebernstein L.P.	314,729	$3.29M	0.0%	-57.3%	0.112%
11/15/2022	State Street Corp	12,022,212	$125.51M	0.0%	-13.6%	4.279%
11/15/2022	Algert Global LLC	215,912	$2.25M	0.1%	+318.9%	0.077%
11/15/2022	Thrivent Financial for Lutherans	12,076	$0.13M	0.0%	N/A	0.004%
11/15/2022	Two Sigma Advisers LP	728,376	$7.60M	0.0%	+18.2%	0.259%
11/15/2022	Two Sigma Investments LP	474,904	$4.96M	0.0%	+31.1%	0.169%
11/15/2022	UBS Asset Management Americas Inc.	220,894	$2.31M	0.0%	-18.6%	0.079%
11/15/2022	Vanguard Group Inc.	25,871,062	$270.10M	0.0%	+0.5%	9.209%
11/15/2022	Perceptive Advisors LLC	27,372,917	$285.77M	8.3%	+1.8%	9.743%
11/15/2022	Price T Rowe Associates Inc. MD	1,458,720	$15.23M	0.0%	-0.5%	0.519%
11/15/2022	Pearl River Capital LLC	26,134	$0.27M	0.1%	N/A	0.009%
11/15/2022	Kynam Capital Management LP	676,849	$7.07M	1.5%	-24.8%	0.241%
11/15/2022	Engineers Gate Manager LP	10,119	$0.11M	0.0%	N/A	0.004%
11/15/2022	Ensign Peak Advisors Inc	56,290	$0.59M	0.0%	-75.9%	0.020%
11/15/2022	First Trust Advisors LP	285,983	$2.99M	0.0%	+112.9%	0.102%
11/15/2022	Bank of New York Mellon Corp	1,229,564	$12.84M	0.0%	+4.8%	0.438%
11/15/2022	Bioimpact Capital LLC	392,946	$4.10M	1.0%	-20.7%	0.140%
11/15/2022	BlackRock Inc.	19,898,552	$207.74M	0.0%	-1.7%	7.083%
11/14/2022	AlphaCrest Capital Management LLC	35,652	$0.37M	0.0%	N/A	0.013%
11/14/2022	Macquarie Group Ltd.	6,877,761	$71.82M	0.1%	+1.6%	2.448%
11/14/2022	Royal Bank of Canada	194,366	$2.03M	0.0%	+3.0%	0.069%
11/14/2022	Point72 Hong Kong Ltd	13,601	$0.14M	0.0%	N/A	0.005%
11/14/2022	Point72 Asset Management L.P.	1,646,400	$17.19M	0.1%	+47.3%	0.586%
11/14/2022	Cubist Systematic Strategies LLC	91,976	$0.96M	0.0%	+324.2%	0.033%
11/14/2022	PDT Partners LLC	30,505	$0.32M	0.0%	N/A	0.011%
11/14/2022	Renaissance Technologies LLC	284,800	$2.97M	0.0%	N/A	0.101%
11/14/2022	Boothbay Fund Management LLC	13,553	$0.14M	0.0%	N/A	0.005%
11/14/2022	Ergoteles LLC	26,269	$0.27M	0.0%	N/A	0.009%
11/14/2022	Nuveen Asset Management LLC	1,130,735	$11.81M	0.0%	-10.4%	0.402%
11/14/2022	Integral Health Asset Management LLC	130,000	$1.36M	0.3%	-81.5%	0.046%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	2,626,600	$27.42M	0.1%	+50.8%	0.935%
11/14/2022	E Fund Management Co. Ltd.	41,712	$0.44M	0.0%	-20.5%	0.015%
11/14/2022	Pictet Asset Management SA	3,485,302	$36.39M	0.1%	+442.0%	1.241%
11/14/2022	Ghost Tree Capital LLC	500,000	$5.22M	1.5%	-50.0%	0.178%
11/14/2022	Oppenheimer Asset Management Inc.	54,872	$0.57M	0.0%	-3.8%	0.020%
11/10/2022	Envestnet Asset Management Inc.	111,821	$1.17M	0.0%	-6.3%	0.040%
11/10/2022	Credit Suisse AG	269,146	$2.81M	0.0%	+5.4%	0.096%
11/10/2022	ExodusPoint Capital Management LP	292,980	$3.06M	0.0%	+126.7%	0.104%
11/10/2022	Seven Eight Capital LP	26,303	$0.28M	0.1%	N/A	0.009%
11/10/2022	Tower Research Capital LLC TRC	88,209	$0.92M	0.0%	+84.6%	0.031%
11/10/2022	Bank of Montreal Can	290,510	$3.04M	0.0%	-53.9%	0.104%
11/10/2022	UBS Group AG	183,591	$1.92M	0.0%	-34.5%	0.065%
11/10/2022	Finepoint Capital LP	1,688,400	$17.63M	5.8%	-16.0%	0.602%
11/9/2022	Amalgamated Bank	44,619	$0.47M	0.0%	+2.4%	0.016%
11/8/2022	Advisors Asset Management Inc.	61,738	$0.65M	0.0%	-2.5%	0.022%
11/8/2022	Allianz Asset Management GmbH	246,274	$2.57M	0.0%	N/A	0.088%
11/8/2022	Mutual of America Capital Management LLC	201,398	$2.10M	0.0%	+9.0%	0.072%
11/7/2022	Inspire Investing LLC	19,774	$0.21M	0.0%	N/A	0.007%
11/7/2022	Rothschild & Co. Asset Management US Inc.	713,946	$7.45M	0.1%	-18.2%	0.255%
11/7/2022	Fox Run Management L.L.C.	12,635	$0.13M	0.1%	N/A	0.005%
11/7/2022	Jump Financial LLC	104,500	$1.09M	0.0%	+45.1%	0.037%
11/7/2022	ProShare Advisors LLC	53,997	$0.56M	0.0%	+2.3%	0.019%
11/4/2022	Prudential Financial Inc.	174,774	$1.83M	0.0%	+737.3%	0.062%
11/4/2022	First Republic Investment Management Inc.	10,278	$0.11M	0.0%	-83.2%	0.004%
11/3/2022	Fiera Capital Corp	4,016,555	$38.12M	0.1%	-1.6%	1.432%
11/3/2022	Duality Advisers LP	184,587	$1.93M	0.2%	N/A	0.066%
11/3/2022	Teacher Retirement System of Texas	68,881	$0.72M	0.0%	+94.3%	0.025%
11/3/2022	The Manufacturers Life Insurance Company	109,303	$1.14M	0.0%	-1.8%	0.039%
11/3/2022	Barclays PLC	405,521	$4.23M	0.0%	+2,111.6%	0.145%
11/3/2022	Parametrica Management Ltd	51,999	$0.54M	1.1%	-61.3%	0.019%
11/2/2022	Victory Capital Management Inc.	141,734	$1.48M	0.0%	+62.6%	0.051%
11/1/2022	Brinker Capital Investments LLC	125,047	$1.31M	0.0%	+18.9%	0.045%
11/1/2022	Rice Hall James & Associates LLC	714,409	$7.46M	0.4%	-21.9%	0.255%
11/1/2022	Great West Life Assurance Co. Can	37,172	$0.39M	0.0%	N/A	0.013%
11/1/2022	Assetmark Inc.	20,570	$0.22M	0.0%	+71.0%	0.007%
10/31/2022	Calton & Associates Inc.	12,427	$0.13M	0.1%	-25.0%	0.004%
10/31/2022	SG Americas Securities LLC	60,447	$0.63M	0.0%	+15.8%	0.022%
10/31/2022	Dupont Capital Management Corp	8,856	$92K	0.0%	-76.3%	0.003%
10/28/2022	State of New Jersey Common Pension Fund D	199,788	$2.09M	0.0%	-31.2%	0.071%
10/27/2022	US Bancorp DE	47,559	$0.50M	0.0%	-3.5%	0.017%
10/27/2022	Strs Ohio	56,100	$0.59M	0.0%	+392.1%	0.020%
10/27/2022	Handelsbanken Fonder AB	29,841	$0.31M	0.0%	-37.9%	0.011%
10/26/2022	Allspring Global Investments Holdings LLC	27,478	$0.29M	0.0%	-5.7%	0.010%
10/26/2022	Peregrine Capital Management LLC	812,361	$8.48M	0.3%	+4.1%	0.290%
10/21/2022	China Universal Asset Management Co. Ltd.	2,627	$27K	0.0%	N/A	0.001%
10/19/2022	Nordea Investment Management AB	652,576	$6.91M	0.0%	-6.2%	0.233%
10/17/2022	Transcend Capital Advisors LLC	215,069	$2.25M	0.2%	+9.6%	0.077%
10/14/2022	Diversified Trust Co	38,175	$0.40M	0.0%	-4.6%	0.014%
10/11/2022	DNB Asset Management AS	21,078	$0.22M	0.0%	-18.0%	0.008%
10/7/2022	Mackenzie Financial Corp	57,251	$0.60M	0.0%	-27.2%	0.020%
8/22/2022	Legal & General Group Plc	220,446	$2.37M	0.0%	-1.3%	0.079%
8/22/2022	ExodusPoint Capital Management LP	129,234	$1.39M	0.0%	N/A	0.046%
8/18/2022	Goldman Sachs Group Inc.	1,372,470	$14.74M	0.0%	-25.3%	0.489%
8/16/2022	First Republic Investment Management Inc.	61,050	$0.66M	0.0%	+431.0%	0.022%
8/16/2022	International Biotechnology Trust PLC	1,017	$95K	1.0%	-98.9%	0.000%
8/16/2022	Price T Rowe Associates Inc. MD	1,465,995	$15.75M	0.0%	+0.3%	0.523%
8/16/2022	Prudential Financial Inc.	20,874	$0.15M	0.0%	-88.7%	0.007%
8/15/2022	AQR Capital Management LLC	86,478	$0.93M	0.0%	-2.7%	0.031%
8/15/2022	Palo Alto Investors LP	9,847,774	$105.77M	9.2%	-0.6%	3.511%
8/15/2022	State Street Corp	13,918,315	$149.48M	0.0%	+16.6%	4.962%
8/15/2022	Macquarie Group Ltd.	6,767,246	$72.68M	0.1%	+3.4%	2.413%
8/15/2022	Cubist Systematic Strategies LLC	21,680	$0.23M	0.0%	+85.1%	0.008%
8/15/2022	Point72 Asset Management L.P.	1,117,900	$12.01M	0.1%	+135.1%	0.399%

Data available starting January 2016

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Today's Range

Now: $11.69

$11.66

$11.94

50 Day Range

MA: $11.03

$9.99

$12.70

52 Week Range

Now: $11.69

$5.91

$12.96

Volume

1,152,128 shs

Average Volume

3,119,989 shs

Market Capitalization

$3.28 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Amicus Therapeutics?: Amicus Therapeutics' top insider shareholders include:
John F Crowley (CEO)
John F Crowley (Chairman)
John F Crowley (CEO)
Bradley L Campbell (CEO)
Bradley L Campbell (COO)
Bradley L Campbell (COO)
Hung Do (Insider)
Daphne Quimi (CFO)
Ellen Rosenberg (Insider)
Samantha Prout (Insider)
Burke W Whitman (Director)
Burke W Whitman (Director)
Lynn Dorsey Bleil (Director)
Margaret G Mcglynn (Director)
Learn More about top insider investors at Amicus Therapeutics.
Who are the major institutional investors of Amicus Therapeutics?: Amicus Therapeutics' top institutional investors include:
Perceptive Advisors LLC — 9.74%
Vanguard Group Inc. — 9.21%
BlackRock Inc. — 7.08%
State Street Corp — 4.28%
Macquarie Group Ltd. — 2.45%
Fiera Capital Corp — 1.43%
Learn More about top institutional investors of Amicus Therapeutics stock.
Which institutional investors are selling Amicus Therapeutics stock?: Within the previous quarter, FOLD stock was sold by these institutional investors:
State Street Corp
Integral Health Asset Management LLC
Ghost Tree Capital LLC
Balyasny Asset Management LLC
Alliancebernstein L.P.
BlackRock Inc.
Bank of Montreal Can
Finepoint Capital LP
Within the previous year, company insiders that have sold Amicus Therapeutics company stock include:
John F Crowley (CEO)
John F Crowley (Chairman)
John F Crowley (CEO)
Bradley L Campbell (CEO)
Bradley L Campbell (COO)
Bradley L Campbell (COO)
Hung Do (Insider)
Learn More investors selling Amicus Therapeutics stock.
Which institutional investors are buying Amicus Therapeutics stock?: In the previous quarter, FOLD stock was bought by institutional investors including:
Pictet Asset Management SA
Healthcare of Ontario Pension Plan Trust Fund
Point72 Asset Management L.P.
Perceptive Advisors LLC
Barclays PLC
Ambassador Advisors LLC
Renaissance Technologies LLC
Allianz Asset Management GmbH
During the previous year, these company insiders have bought Amicus Therapeutics stock:
John F Crowley (CEO)
John F Crowley (Chairman)
John F Crowley (CEO)
Learn More investors buying Amicus Therapeutics stock.

Nobel Prize Winner's Premonition About Nuclear Energy Comes True

From Investing Trends | Ad

Will This Nuclear Revival Send Uranium A Bull Run?

FOLD Insider Trading

Amicus Therapeutics Insider Trading History Chart

Amicus Therapeutics Share Price & Price History

Amicus Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Amicus Therapeutics (NASDAQ:FOLD)

Institutional Buying and Selling by Quarter

Amicus Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Amicus Therapeutics?

Who are the major institutional investors of Amicus Therapeutics?

Which institutional investors are selling Amicus Therapeutics stock?

Which institutional investors are buying Amicus Therapeutics stock?